Welcome to the fourth installment of Arnold & Porter's Virtual and Digital Health Digest. This edition primarily covers January 2023 highlights across the virtual and digital health space. This digest focuses on key virtual and digital health and telehealth-related developments in the United States, United Kingdom, and European Union in the healthcare, regulatory, intellectual property, and privacy spaces.
In this issue, you will find the following:
US News
- FDA Regulatory Updates
- Healthcare Fraud and Abuse Updates
- Provider Reimbursement Updates
- Privacy Updates
EU and UK News
- Regulatory Updates
- Privacy Updates
- Reimbursement Updates
- Product Liability Updates
- Intellectual Property Updates
Since going to press with this edition, the DEA announced pending publication of a proposed rule addressing permanent regulatory telemedicine flexibilities associated with prescribing Schedules III and IV drugs. The full text of the proposals may be found here and here. Stay tuned for more information in our next edition.
Click here for additional issues of the Virtual and Digital Health Digest
Click here to opt into our mailing list for future issues of the Virtual and Digital Health Digest
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.